<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2017-05-10" version="179">
<accession>P48730</accession>
<accession>A2I2P2</accession>
<accession>Q96KZ6</accession>
<accession>Q9BTN5</accession>
<name>KC1D_HUMAN</name>
<protein>
<recommendedName>
<fullName>Casein kinase I isoform delta</fullName>
<shortName>CKI-delta</shortName>
<shortName>CKId</shortName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Tau-protein kinase CSNK1D</fullName>
<ecNumber>2.7.11.26</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary">CSNK1D</name>
<name type="synonym">HCKID</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Genomics" volume="32" first="140" last="143">
<title>Sequence analysis of the cDNA for the human casein kinase I delta (CSNK1D) gene and its chromosomal localization.</title>
<authorList>
<person name="Kusuda J."/>
<person name="Hidari N."/>
<person name="Hidari M."/>
<person name="Hashimoto K."/>
</authorList>
<dbReference type="PubMed" id="8786104"/>
<dbReference type="DOI" id="10.1006/geno.1996.0091"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Blood" volume="103" first="2997" last="3004">
<title>Involvement of casein kinase Iepsilon in cytokine-induced granulocytic differentiation.</title>
<authorList>
<person name="Okamura A."/>
<person name="Iwata N."/>
<person name="Nagata A."/>
<person name="Tamekane A."/>
<person name="Shimoyama M."/>
<person name="Gomyo H."/>
<person name="Yakushijin K."/>
<person name="Urahama N."/>
<person name="Hamaguchi M."/>
<person name="Fukui C."/>
<person name="Chihara K."/>
<person name="Ito M."/>
<person name="Matsui T."/>
</authorList>
<dbReference type="PubMed" id="15070676"/>
<dbReference type="DOI" id="10.1182/blood-2003-08-2768"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Hematopoietic stem cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2006-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Placenta</tissue>
<tissue>Spleen</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="15980" last="15984">
<title>Regulation of casein kinase I epsilon and casein kinase I delta by an in vivo futile phosphorylation cycle.</title>
<authorList>
<person name="Rivers A."/>
<person name="Gietzen K.F."/>
<person name="Vielhaber E."/>
<person name="Virshup D.M."/>
</authorList>
<dbReference type="PubMed" id="9632646"/>
<dbReference type="DOI" id="10.1074/jbc.273.26.15980"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="FEBS Lett." volume="463" first="312" last="316">
<title>Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15.</title>
<authorList>
<person name="Dumaz N."/>
<person name="Milne D.M."/>
<person name="Meek D.W."/>
</authorList>
<dbReference type="PubMed" id="10606744"/>
<dbReference type="DOI" id="10.1016/S0014-5793(99)01647-6"/>
</citation>
<scope>FUNCTION AS TP53 KINASE</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2000" name="Eur. J. Cell Biol." volume="79" first="240" last="251">
<title>Interaction of casein kinase 1 delta (CK1delta) with post-Golgi structures, microtubules and the spindle apparatus.</title>
<authorList>
<person name="Behrend L."/>
<person name="Stoeter M."/>
<person name="Kurth M."/>
<person name="Rutter G."/>
<person name="Heukeshoven J."/>
<person name="Deppert W."/>
<person name="Knippschild U."/>
</authorList>
<dbReference type="PubMed" id="10826492"/>
<dbReference type="DOI" id="10.1078/S0171-9335(04)70027-8"/>
</citation>
<scope>INTERACTION WITH TUBULINS</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="Exp. Cell Res." volume="263" first="43" last="54">
<title>Catalytic activity of protein kinase CK1 delta (casein kinase 1delta) is essential for its normal subcellular localization.</title>
<authorList>
<person name="Milne D.M."/>
<person name="Looby P."/>
<person name="Meek D.W."/>
</authorList>
<dbReference type="PubMed" id="11161704"/>
<dbReference type="DOI" id="10.1006/excr.2000.5100"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-38 AND THR-176</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="FEBS Lett." volume="489" first="159" last="165">
<title>Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2.</title>
<authorList>
<person name="Camacho F."/>
<person name="Cilio M."/>
<person name="Guo Y."/>
<person name="Virshup D.M."/>
<person name="Patel K."/>
<person name="Khorkova O."/>
<person name="Styren S."/>
<person name="Morse B."/>
<person name="Yao Z."/>
<person name="Keesler G.A."/>
</authorList>
<dbReference type="PubMed" id="11165242"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)02434-0"/>
</citation>
<scope>INTERACTION WITH PER1 AND PER2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="44962" last="44968">
<title>Casein kinase 1 regulates connexin-43 gap junction assembly.</title>
<authorList>
<person name="Cooper C.D."/>
<person name="Lampe P.D."/>
</authorList>
<dbReference type="PubMed" id="12270943"/>
<dbReference type="DOI" id="10.1074/jbc.M209427200"/>
</citation>
<scope>FUNCTION AS CONNEXIN-43/GJA1 KINASE</scope>
<scope>INTERACTION WITH CONNEXIN-43/GJA1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Mol. Biol." volume="322" first="785" last="797">
<title>Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450.</title>
<authorList>
<person name="Sillibourne J.E."/>
<person name="Milne D.M."/>
<person name="Takahashi M."/>
<person name="Ono Y."/>
<person name="Meek D.W."/>
</authorList>
<dbReference type="PubMed" id="12270714"/>
<dbReference type="DOI" id="10.1016/S0022-2836(02)00857-4"/>
</citation>
<scope>INTERACTION WITH AKAP9/AKAP450</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15938" last="15945">
<title>Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules.</title>
<authorList>
<person name="Li G."/>
<person name="Yin H."/>
<person name="Kuret J."/>
</authorList>
<dbReference type="PubMed" id="14761950"/>
<dbReference type="DOI" id="10.1074/jbc.M314116200"/>
</citation>
<scope>FUNCTION AS MAPT/TAU KINASE</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH MAPT/TAU</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="7964" last="7975">
<title>Inhibition of casein kinase I delta alters mitotic spindle formation and induces apoptosis in trophoblast cells.</title>
<authorList>
<person name="Stoeter M."/>
<person name="Bamberger A.-M."/>
<person name="Aslan B."/>
<person name="Kurth M."/>
<person name="Speidel D."/>
<person name="Loening T."/>
<person name="Frank H.-G."/>
<person name="Kaufmann P."/>
<person name="Loehler J."/>
<person name="Henne-Bruns D."/>
<person name="Deppert W."/>
<person name="Knippschild U."/>
</authorList>
<dbReference type="PubMed" id="16027726"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208941"/>
</citation>
<scope>FUNCTION IN MITOTIC SPINDLE FORMATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Biochemistry" volume="45" first="5297" last="5308">
<title>Dysbindin structural homologue CK1BP is an isoform-selective binding partner of human casein kinase-1.</title>
<authorList>
<person name="Yin H."/>
<person name="Laguna K.A."/>
<person name="Li G."/>
<person name="Kuret J."/>
</authorList>
<dbReference type="PubMed" id="16618118"/>
<dbReference type="DOI" id="10.1021/bi052354e"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH DBNDD2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="EMBO J." volume="26" first="4619" last="4633">
<title>Phosphorylation at Ser244 by CK1 determines nuclear localization and substrate targeting of PKD2.</title>
<authorList>
<person name="von Blume J."/>
<person name="Knippschild U."/>
<person name="Dequiedt F."/>
<person name="Giamas G."/>
<person name="Beck A."/>
<person name="Auer A."/>
<person name="Van Lint J."/>
<person name="Adler G."/>
<person name="Seufferlein T."/>
</authorList>
<dbReference type="PubMed" id="17962809"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601891"/>
</citation>
<scope>FUNCTION AS PKD2 KINASE</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="23645" last="23654">
<title>Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis.</title>
<authorList>
<person name="Hanger D.P."/>
<person name="Byers H.L."/>
<person name="Wray S."/>
<person name="Leung K.-Y."/>
<person name="Saxton M.J."/>
<person name="Seereeram A."/>
<person name="Reynolds C.H."/>
<person name="Ward M.A."/>
<person name="Anderton B.H."/>
</authorList>
<dbReference type="PubMed" id="17562708"/>
<dbReference type="DOI" id="10.1074/jbc.M703269200"/>
</citation>
<scope>FUNCTION AS MAPT/TAU KINASE</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331 AND SER-384</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="J. Med. Chem." volume="52" first="7618" last="7630">
<title>3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.</title>
<authorList>
<person name="Peifer C."/>
<person name="Abadleh M."/>
<person name="Bischof J."/>
<person name="Hauser D."/>
<person name="Schattel V."/>
<person name="Hirner H."/>
<person name="Knippschild U."/>
<person name="Laufer S."/>
</authorList>
<dbReference type="PubMed" id="19591487"/>
<dbReference type="DOI" id="10.1021/jm9005127"/>
</citation>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="382" last="392">
<title>Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.</title>
<authorList>
<person name="Grozav A.G."/>
<person name="Chikamori K."/>
<person name="Kozuki T."/>
<person name="Grabowski D.R."/>
<person name="Bukowski R.M."/>
<person name="Willard B."/>
<person name="Kinter M."/>
<person name="Andersen A.H."/>
<person name="Ganapathi R."/>
<person name="Ganapathi M.K."/>
</authorList>
<dbReference type="PubMed" id="19043076"/>
<dbReference type="DOI" id="10.1093/nar/gkn934"/>
</citation>
<scope>FUNCTION AS TOP2A KINASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="3110" last="3123">
<title>CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.</title>
<authorList>
<person name="Giamas G."/>
<person name="Castellano L."/>
<person name="Feng Q."/>
<person name="Knippschild U."/>
<person name="Jacob J."/>
<person name="Thomas R.S."/>
<person name="Coombes R.C."/>
<person name="Smith C.L."/>
<person name="Jiao L.R."/>
<person name="Stebbing J."/>
</authorList>
<dbReference type="PubMed" id="19339517"/>
<dbReference type="DOI" id="10.1093/nar/gkp136"/>
</citation>
<scope>FUNCTION AS AIB1/NCOA3 AND ESR1 KINASE</scope>
<scope>INTERACTION WITH AIB1/NCOA3 AND ESR1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Arch. Biochem. Biophys." volume="502" first="44" last="52">
<title>Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity.</title>
<authorList>
<person name="Smal C."/>
<person name="Vertommen D."/>
<person name="Amsailale R."/>
<person name="Arts A."/>
<person name="Degand H."/>
<person name="Morsomme P."/>
<person name="Rider M.H."/>
<person name="Neste E.V."/>
<person name="Bontemps F."/>
</authorList>
<dbReference type="PubMed" id="20637175"/>
<dbReference type="DOI" id="10.1016/j.abb.2010.07.009"/>
</citation>
<scope>FUNCTION AS DCK KINASE</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Cell. Mol. Life Sci." volume="67" first="1105" last="1118">
<title>Isoform specific phosphorylation of p53 by protein kinase CK1.</title>
<authorList>
<person name="Venerando A."/>
<person name="Marin O."/>
<person name="Cozza G."/>
<person name="Bustos V.H."/>
<person name="Sarno S."/>
<person name="Pinna L.A."/>
</authorList>
<dbReference type="PubMed" id="20041275"/>
<dbReference type="DOI" id="10.1007/s00018-009-0236-7"/>
</citation>
<scope>FUNCTION AS P53/TP53 KINASE</scope>
<scope>GENE FAMILY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Genes Dev." volume="24" first="72" last="85">
<title>A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).</title>
<authorList>
<person name="Zhao B."/>
<person name="Li L."/>
<person name="Tumaneng K."/>
<person name="Wang C.-Y."/>
<person name="Guan K.-L."/>
</authorList>
<dbReference type="PubMed" id="20048001"/>
<dbReference type="DOI" id="10.1101/gad.1843810"/>
</citation>
<scope>FUNCTION AS YAP1 KINASE</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="2976" last="2986">
<title>Casein kinase 1 regulates human hypoxia-inducible factor HIF-1.</title>
<authorList>
<person name="Kalousi A."/>
<person name="Mylonis I."/>
<person name="Politou A.S."/>
<person name="Chachami G."/>
<person name="Paraskeva E."/>
<person name="Simos G."/>
</authorList>
<dbReference type="PubMed" id="20699359"/>
<dbReference type="DOI" id="10.1242/jcs.068122"/>
</citation>
<scope>FUNCTION AS HIF1A KINASE</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="15240" last="15245">
<title>Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes.</title>
<authorList>
<person name="Meng Q.-J."/>
<person name="Maywood E.S."/>
<person name="Bechtold D.A."/>
<person name="Lu W.-Q."/>
<person name="Li J."/>
<person name="Gibbs J.E."/>
<person name="Dupre S.M."/>
<person name="Chesham J.E."/>
<person name="Rajamohan F."/>
<person name="Knafels J."/>
<person name="Sneed B."/>
<person name="Zawadzke L.E."/>
<person name="Ohren J.F."/>
<person name="Walton K.M."/>
<person name="Wager T.T."/>
<person name="Hastings M.H."/>
<person name="Loudon A.S.I."/>
</authorList>
<dbReference type="PubMed" id="20696890"/>
<dbReference type="DOI" id="10.1073/pnas.1005101107"/>
</citation>
<scope>FUNCTION IN CIRCADIAN RHYTHMS</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="Psychopharmacology" volume="210" first="569" last="576">
<title>Chronic treatment with a selective inhibitor of casein kinase I delta/epsilon yields cumulative phase delays in circadian rhythms.</title>
<authorList>
<person name="Sprouse J."/>
<person name="Reynolds L."/>
<person name="Kleiman R."/>
<person name="Tate B."/>
<person name="Swanson T.A."/>
<person name="Pickard G.E."/>
</authorList>
<dbReference type="PubMed" id="20407760"/>
<dbReference type="DOI" id="10.1007/s00213-010-1860-5"/>
</citation>
<scope>FUNCTION IN CIRCADIAN RHYTHMS</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="3129" last="3138">
<title>Opposing action of casein kinase 1 and calcineurin in nucleo-cytoplasmic shuttling of mammalian translation initiation factor eIF6.</title>
<authorList>
<person name="Biswas A."/>
<person name="Mukherjee S."/>
<person name="Das S."/>
<person name="Shields D."/>
<person name="Chow C.W."/>
<person name="Maitra U."/>
</authorList>
<dbReference type="PubMed" id="21084295"/>
<dbReference type="DOI" id="10.1074/jbc.M110.188565"/>
</citation>
<scope>FUNCTION AS EIF6 KINASE</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="J. Cell Biol." volume="192" first="993" last="1004">
<title>Casein kinase 1 delta functions at the centrosome to mediate Wnt-3a-dependent neurite outgrowth.</title>
<authorList>
<person name="Greer Y.E."/>
<person name="Rubin J.S."/>
</authorList>
<dbReference type="PubMed" id="21422228"/>
<dbReference type="DOI" id="10.1083/jcb.201011111"/>
</citation>
<scope>FUNCTION AS DVL2 AND DVL3 KINASE</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="Oncogene" volume="30" first="2558" last="2569">
<title>IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1delta/epsilon and Wnt/beta-catenin independent inhibition of mitotic spindle formation.</title>
<authorList>
<person name="Cheong J.K."/>
<person name="Nguyen T.H."/>
<person name="Wang H."/>
<person name="Tan P."/>
<person name="Voorhoeve P.M."/>
<person name="Lee S.H."/>
<person name="Virshup D.M."/>
</authorList>
<dbReference type="PubMed" id="21258417"/>
<dbReference type="DOI" id="10.1038/onc.2010.627"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Int. J. Biochem. Cell Biol." volume="43" first="465" last="469">
<title>Casein kinase 1: Complexity in the family.</title>
<authorList>
<person name="Cheong J.K."/>
<person name="Virshup D.M."/>
</authorList>
<dbReference type="PubMed" id="21145983"/>
<dbReference type="DOI" id="10.1016/j.biocel.2010.12.004"/>
</citation>
<scope>REVIEW ON CIRCADIAN RHYTHMS</scope>
<scope>GENE FAMILY</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328; SER-331; SER-382; SER-384 AND SER-407</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="1998" name="Acta Crystallogr. D" volume="54" first="473" last="475">
<title>Crystallographic studies of casein kinase I delta toward a structural understanding of auto-inhibition.</title>
<authorList>
<person name="Longenecker K.L."/>
<person name="Roach P.J."/>
<person name="Hurley T.D."/>
</authorList>
<dbReference type="PubMed" id="9761932"/>
<dbReference type="DOI" id="10.1107/S0907444997011724"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS)</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="J. Med. Chem." volume="55" first="956" last="960">
<title>Structural basis for the interaction between casein kinase 1 delta and a potent and selective inhibitor.</title>
<authorList>
<person name="Long A."/>
<person name="Zhao H."/>
<person name="Huang X."/>
</authorList>
<dbReference type="PubMed" id="22168824"/>
<dbReference type="DOI" id="10.1021/jm201387s"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 1-294 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="J. Med. Chem." volume="55" first="10307" last="10311">
<title>Structural basis for the potent and selective inhibition of casein kinase 1 epsilon.</title>
<authorList>
<person name="Long A.M."/>
<person name="Zhao H."/>
<person name="Huang X."/>
</authorList>
<dbReference type="PubMed" id="23106386"/>
<dbReference type="DOI" id="10.1021/jm301336n"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 1-294 IN COMPLEX WITH INHIBITOR</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2005" name="Nature" volume="434" first="640" last="644">
<title>Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome.</title>
<authorList>
<person name="Xu Y."/>
<person name="Padiath Q.S."/>
<person name="Shapiro R.E."/>
<person name="Jones C.R."/>
<person name="Wu S.C."/>
<person name="Saigoh N."/>
<person name="Saigoh K."/>
<person name="Ptacek L.J."/>
<person name="Fu Y.H."/>
</authorList>
<dbReference type="PubMed" id="15800623"/>
<dbReference type="DOI" id="10.1038/nature03453"/>
</citation>
<scope>VARIANT FASPS2 ALA-44</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] CYS-97</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] CYS-97 AND ALA-401</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="Sci. Transl. Med." volume="5" first="183ra56" last="183ra56">
<title>Casein kinase idelta mutations in familial migraine and advanced phase.</title>
<authorList>
<person name="Brennan K.C."/>
<person name="Bates E.A."/>
<person name="Shapiro R.E."/>
<person name="Zyuzin J."/>
<person name="Hallows W.C."/>
<person name="Huang Y."/>
<person name="Lee H.Y."/>
<person name="Jones C.R."/>
<person name="Fu Y.H."/>
<person name="Charles A.C."/>
<person name="Ptacek L.J."/>
</authorList>
<dbReference type="PubMed" id="23636092"/>
<dbReference type="DOI" id="10.1126/scitranslmed.3005784"/>
</citation>
<scope>VARIANTS FASPS2 ALA-44 AND ARG-46</scope>
<scope>CHARACTERIZATION OF VARIANTS FASPS2 ALA-44 AND ARG-46</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<comment type="function">
<text evidence="12 17 18 21 25 26 27 28 30 31 32 33 34 35 36 38 41">Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. In balance with PP1, determines the circadian period length through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. Controls PER1 and PER2 nuclear transport and degradation. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [tau protein] = ADP + [tau protein] phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="18 21 27 29 32 34 36 37 38 42">Exhibits substrate-dependent heparin activation. Drug-mediated inhibition leads to a delay of the oscillations with the magnitude of this effect dependent upon the timing of drug administration. Inhibited by phosphorylation. Repressed by 3-[(2,4,6-trimethoxyphenyl)methylidenyl]-indolin-2-one (IC261), N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide (CKI-7), 4-[4-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-pyridin-2-yl-1H-imidazol-2-yl]benzamide (D4476), 3,4-diaryl-isoxazoles and -imidazoles, and 4-(3-cyclohexyl-5-(4-fluoro-phenyl)-3H-imidazol-4-yl) pyrimidin-2-ylamine (PF670462, PF670).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="41">36.5 uM for alpha-casein</KM>
<KM evidence="41">635.8 uM for PER2 peptide</KM>
<KM evidence="41">180.6 uM for ATP</KM>
<text>Maximal velocity nearly identical for the reactions with alpha-casein and PER2 peptide.</text>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="7 13 15 16 17 18 22 28 39 40">Binds to DNMT1 and MAP1A (By similarity). Monomer. Component of the circadian core oscillator, which includes the CRY proteins, CLOCK, or NPAS2, ARTNL/BMAL1 or ARTNL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS and the PER proteins. Interacts directly with PER1 and PER2 which may lead to their degradation. Interacts with MAPT/TAU, SNAPIN, DBNDD2, AIB1/NCOA3 and ESR1. AKAP9/AKAP450 binding promotes centrosomal subcellular location. Binds to tubulins in mitotic cells upon DNA damage.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751621"/>
<interactant intactId="EBI-641940">
<id>Q60838</id>
<label>Dvl2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751621"/>
<interactant intactId="EBI-739789">
<id>Q92997</id>
<label>DVL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751621"/>
<interactant intactId="EBI-741355">
<id>Q96LR2</id>
<label>LURAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751621"/>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-751621"/>
<interactant intactId="EBI-720828">
<id>Q9C026</id>
<label>TRIM9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9087876"/>
<interactant intactId="EBI-524753">
<id>Q8IUH5</id>
<label>ZDHHC17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Microtubule organizing center</location>
<location>Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Spindle</location>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus</location>
</subcellularLocation>
<text>Localized at mitotic spindle microtubules, and at the centrosomes and interphase in interphase cells. Recruited to the spindle apparatus and the centrosomes in response to DNA-damage. Correct subcellular localization requires kinase activity.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P48730-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P48730-2</id>
<name>2</name>
<sequence type="described" ref="VSP_010253"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="19 21">Expressed in all tissues examined, including brain, heart, lung, liver, pancreas, kidney, placenta and skeletal muscle. However, kinase activity is not uniform, with highest kinase activity in splenocytes. In blood, highly expressed in hemopoietic cells and mature granulocytes. Also found in monocytes and lymphocytes.</text>
</comment>
<comment type="developmental stage">
<text evidence="21">Highly present in extravillous trophoblast cells, which are present at the placenta implantation site and invade the decidua and decidual vessels.</text>
</comment>
<comment type="PTM">
<text>Autophosphorylated on serine and threonine residues; this autophosphorylation represses activity. Reactivated by phosphatase-mediated dephosphorylation. May be dephosphorylated by PP1.</text>
</comment>
<comment type="disease" evidence="20 41">
<disease id="DI-03718">
<name>Advanced sleep phase syndrome, familial, 2</name>
<acronym>FASPS2</acronym>
<description>A disorder characterized by very early sleep onset and offset. Individuals are 'morning larks' with a 4 hours advance of the sleep, temperature and melatonin rhythms.</description>
<dbReference type="MIM" id="615224"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text evidence="46">May be involved in Alzheimer disease by phosphorylating MAPT/TAU.</text>
</comment>
<comment type="similarity">
<text evidence="45">Belongs to the protein kinase superfamily. CK1 Ser/Thr protein kinase family. Casein kinase I subfamily.</text>
</comment>
<comment type="caution">
<text evidence="47">Was shown to phosphorylate and activate DCK in vitro but probably not in vivo.</text>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EC" id="2.7.11.26"/>
<dbReference type="EMBL" id="U29171">
<property type="protein sequence ID" value="AAC50807.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U31285">
<property type="protein sequence ID" value="AAC50808.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB091044">
<property type="protein sequence ID" value="BAC10903.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK291758">
<property type="protein sequence ID" value="BAF84447.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF015900">
<property type="protein sequence ID" value="ABM64211.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003558">
<property type="protein sequence ID" value="AAH03558.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015775">
<property type="protein sequence ID" value="AAH15775.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11805.1">
<molecule id="P48730-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11806.1">
<molecule id="P48730-2"/>
</dbReference>
<dbReference type="PIR" id="G01876">
<property type="entry name" value="G01876"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001884.2">
<molecule id="P48730-1"/>
<property type="nucleotide sequence ID" value="NM_001893.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_620693.1">
<molecule id="P48730-2"/>
<property type="nucleotide sequence ID" value="NM_139062.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.631725"/>
<dbReference type="PDB" id="3UYS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/B/C/D=1-294"/>
</dbReference>
<dbReference type="PDB" id="3UYT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=1-294"/>
</dbReference>
<dbReference type="PDB" id="3UZP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.94"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4HGT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4HNF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4KB8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B/C/D=3-317"/>
</dbReference>
<dbReference type="PDB" id="4KBA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B/C/D=3-317"/>
</dbReference>
<dbReference type="PDB" id="4KBC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.98"/>
<property type="chains" value="A/B=1-317"/>
</dbReference>
<dbReference type="PDB" id="4KBK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B/C/D=3-317"/>
</dbReference>
<dbReference type="PDB" id="4TN6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.41"/>
<property type="chains" value="A/B=1-301"/>
</dbReference>
<dbReference type="PDB" id="4TW9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-295"/>
</dbReference>
<dbReference type="PDB" id="4TWC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=1-295"/>
</dbReference>
<dbReference type="PDB" id="5IH4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1-294"/>
</dbReference>
<dbReference type="PDB" id="5IH5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=1-294"/>
</dbReference>
<dbReference type="PDB" id="5IH6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-294"/>
</dbReference>
<dbReference type="PDBsum" id="3UYS"/>
<dbReference type="PDBsum" id="3UYT"/>
<dbReference type="PDBsum" id="3UZP"/>
<dbReference type="PDBsum" id="4HGT"/>
<dbReference type="PDBsum" id="4HNF"/>
<dbReference type="PDBsum" id="4KB8"/>
<dbReference type="PDBsum" id="4KBA"/>
<dbReference type="PDBsum" id="4KBC"/>
<dbReference type="PDBsum" id="4KBK"/>
<dbReference type="PDBsum" id="4TN6"/>
<dbReference type="PDBsum" id="4TW9"/>
<dbReference type="PDBsum" id="4TWC"/>
<dbReference type="PDBsum" id="5IH4"/>
<dbReference type="PDBsum" id="5IH5"/>
<dbReference type="PDBsum" id="5IH6"/>
<dbReference type="ProteinModelPortal" id="P48730"/>
<dbReference type="SMR" id="P48730"/>
<dbReference type="BioGrid" id="107837">
<property type="interactions" value="85"/>
</dbReference>
<dbReference type="DIP" id="DIP-39735N"/>
<dbReference type="IntAct" id="P48730">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="MINT" id="MINT-1454355"/>
<dbReference type="STRING" id="9606.ENSP00000324464"/>
<dbReference type="BindingDB" id="P48730"/>
<dbReference type="ChEMBL" id="CHEMBL2828"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1997"/>
<dbReference type="iPTMnet" id="P48730"/>
<dbReference type="PhosphoSitePlus" id="P48730"/>
<dbReference type="BioMuta" id="CSNK1D"/>
<dbReference type="DMDM" id="27923980"/>
<dbReference type="EPD" id="P48730"/>
<dbReference type="MaxQB" id="P48730"/>
<dbReference type="PaxDb" id="P48730"/>
<dbReference type="PeptideAtlas" id="P48730"/>
<dbReference type="PRIDE" id="P48730"/>
<dbReference type="TopDownProteomics" id="P48730-1">
<molecule id="P48730-1"/>
</dbReference>
<dbReference type="DNASU" id="1453"/>
<dbReference type="Ensembl" id="ENST00000314028">
<molecule id="P48730-1"/>
<property type="protein sequence ID" value="ENSP00000324464"/>
<property type="gene ID" value="ENSG00000141551"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000392334">
<molecule id="P48730-2"/>
<property type="protein sequence ID" value="ENSP00000376146"/>
<property type="gene ID" value="ENSG00000141551"/>
</dbReference>
<dbReference type="GeneID" id="1453"/>
<dbReference type="KEGG" id="hsa:1453"/>
<dbReference type="UCSC" id="uc002kei.4">
<molecule id="P48730-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1453"/>
<dbReference type="DisGeNET" id="1453"/>
<dbReference type="GeneCards" id="CSNK1D"/>
<dbReference type="HGNC" id="HGNC:2452">
<property type="gene designation" value="CSNK1D"/>
</dbReference>
<dbReference type="HPA" id="CAB015410"/>
<dbReference type="MalaCards" id="CSNK1D"/>
<dbReference type="MIM" id="600864">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615224">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P48730"/>
<dbReference type="OpenTargets" id="ENSG00000141551"/>
<dbReference type="Orphanet" id="164736">
<property type="disease" value="Familial advanced sleep-phase syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26952"/>
<dbReference type="eggNOG" id="KOG1164">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XPGP">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119040"/>
<dbReference type="HOGENOM" id="HOG000182055"/>
<dbReference type="HOVERGEN" id="HBG000176"/>
<dbReference type="InParanoid" id="P48730"/>
<dbReference type="KO" id="K08959"/>
<dbReference type="PhylomeDB" id="P48730"/>
<dbReference type="TreeFam" id="TF300544"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-204005">
<property type="pathway name" value="COPII (Coat Protein 2) Mediated Vesicle Transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2565942">
<property type="pathway name" value="Regulation of PLK1 Activity at G2/M Transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380259">
<property type="pathway name" value="Loss of Nlp from mitotic centrosomes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380270">
<property type="pathway name" value="Recruitment of mitotic centrosome proteins and complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380284">
<property type="pathway name" value="Loss of proteins required for interphase microtubule organization from the centrosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5620912">
<property type="pathway name" value="Anchoring of the basal body to the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6791226">
<property type="pathway name" value="Major pathway of rRNA processing in the nucleolus and cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8854518">
<property type="pathway name" value="AURKA Activation by TPX2"/>
</dbReference>
<dbReference type="SABIO-RK" id="P48730"/>
<dbReference type="SignaLink" id="P48730"/>
<dbReference type="SIGNOR" id="P48730"/>
<dbReference type="ChiTaRS" id="CSNK1D">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CSNK1D"/>
<dbReference type="GenomeRNAi" id="1453"/>
<dbReference type="PRO" id="PR:P48730"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141551"/>
<dbReference type="CleanEx" id="HS_CSNK1D"/>
<dbReference type="ExpressionAtlas" id="P48730">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P48730">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033116">
<property type="term" value="C:endoplasmic reticulum-Golgi intermediate compartment membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005876">
<property type="term" value="C:spindle microtubule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001948">
<property type="term" value="F:glycoprotein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042277">
<property type="term" value="F:peptide binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050321">
<property type="term" value="F:tau-protein kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:1990090">
<property type="term" value="P:cellular response to nerve growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097711">
<property type="term" value="P:ciliary basal body docking"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048208">
<property type="term" value="P:COPII vesicle coating"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006897">
<property type="term" value="P:endocytosis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000086">
<property type="term" value="P:G2/M transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007030">
<property type="term" value="P:Golgi organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="SYSCILIA_CCNET"/>
</dbReference>
<dbReference type="GO" id="GO:0007020">
<property type="term" value="P:microtubule nucleation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="SYSCILIA_CCNET"/>
</dbReference>
<dbReference type="GO" id="GO:1905515">
<property type="term" value="P:non-motile cilium assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="SYSCILIA_CCNET"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090263">
<property type="term" value="P:positive regulation of canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000052">
<property type="term" value="P:positive regulation of non-canonical Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905426">
<property type="term" value="P:positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071539">
<property type="term" value="P:protein localization to centrosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="SYSCILIA_CCNET"/>
</dbReference>
<dbReference type="GO" id="GO:0061512">
<property type="term" value="P:protein localization to cilium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="SYSCILIA_CCNET"/>
</dbReference>
<dbReference type="GO" id="GO:0034067">
<property type="term" value="P:protein localization to Golgi apparatus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="SYSCILIA_CCNET"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008360">
<property type="term" value="P:regulation of cell shape"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006364">
<property type="term" value="P:rRNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051225">
<property type="term" value="P:spindle assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016055">
<property type="term" value="P:Wnt signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0879">Wnt signaling pathway</keyword>
<feature type="chain" description="Casein kinase I isoform delta" id="PRO_0000192833">
<location>
<begin position="1"/>
<end position="415"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="10">
<location>
<begin position="9"/>
<end position="277"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10">
<location>
<begin position="15"/>
<end position="23"/>
</location>
</feature>
<feature type="region of interest" description="Centrosomal localization signal (CLS)">
<location>
<begin position="278"/>
<end position="364"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory" evidence="7">
<location>
<begin position="317"/>
<end position="342"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="10 11">
<location>
<position position="128"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="10">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="370"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="9">
<location>
<position position="375"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="382"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="383"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 6">
<location>
<position position="384"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="407"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="411"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_010253" evidence="43 44">
<original>IPGRVASSGLQSVVHR</original>
<variation>NSIPFEHHGK</variation>
<location>
<begin position="400"/>
<end position="415"/>
</location>
</feature>
<feature type="sequence variant" description="In FASPS2; strongly reduces kinase activity; dbSNP:rs104894561." id="VAR_029075" evidence="20 41">
<original>T</original>
<variation>A</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="sequence variant" description="In FASPS2; strongly reduces kinase activity; dbSNP:rs397514693." id="VAR_069801" evidence="41">
<original>H</original>
<variation>R</variation>
<location>
<position position="46"/>
</location>
</feature>
<feature type="sequence variant" description="In breast cancer samples; infiltrating ductal carcinoma; somatic mutation." id="VAR_036451" evidence="23 24">
<original>S</original>
<variation>C</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56124628." id="VAR_042081" evidence="24">
<original>P</original>
<variation>A</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus." evidence="14">
<original>K</original>
<variation>M</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus." evidence="14">
<original>T</original>
<variation>I</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC50807." ref="1" evidence="45">
<original>A</original>
<variation>D</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="3"/>
<end position="5"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="6"/>
<end position="8"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="9"/>
<end position="16"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="21"/>
<end position="28"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="29"/>
<end position="32"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="33"/>
<end position="41"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="49"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="68"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="77"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="89"/>
<end position="95"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="102"/>
<end position="121"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="131"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="134"/>
<end position="136"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="145"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="154"/>
<end position="157"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="177"/>
<end position="179"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="182"/>
<end position="185"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="192"/>
<end position="208"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="212"/>
<end position="215"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="223"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="237"/>
<end position="240"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="241"/>
<end position="243"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="247"/>
<end position="257"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="266"/>
<end position="279"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="289"/>
<end position="292"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KB8"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4TWC"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q06486"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9DC28"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10606744"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10826492"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11161704"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11165242"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12270714"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12270943"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14761950"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15070676"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15800623"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16027726"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16618118"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17562708"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17962809"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19043076"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19339517"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19591487"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20041275"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20048001"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20407760"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20637175"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20696890"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20699359"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21084295"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21258417"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21422228"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22168824"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23106386"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23636092"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9632646"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305"/>
<evidence key="46" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="17562708"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="20637175"/>
</source>
</evidence>
<sequence length="415" mass="47330" checksum="B97F1717A52466D2" modified="2003-01-27" version="2">
MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ
GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH
SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA
SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL
CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRA
ADDAERERRDREERLRHSRNPATRGLPSTASGRLRGTQEVAPPTPLTPTSHTANTSPRPV
SGMERERKVSMRLHRGAPVNISSSDLTGRQDTSRMSTSQIPGRVASSGLQSVVHR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>